With India currently having 10 billion doses worth of vaccine capacity and the Serum Institute of India (SII) accounting for about 4 billion, SII CEO Adar Poonawala said, “I think the world will always, in some way or another, be dependent on India."
Speaking at the World Economic Forum in Davos, Switzerland, Poonawala said SII has shipped vaccines from India to the US, Novavax's Nuvaxovid vaccine which was a first.